N-Boc-5-methyl-D-tryptophan

Catalog No. :
ACBHGN835
CAS No. :
114873-18-6
Molecular Formula :
C17H22N2O4
Molecular Weight :
318.37

IUPAC Name:(R)-2-((tert-butoxycarbonyl)amino)-3-(5-methyl-1H-indol-3-yl)propanoic acid

N-Boc-5-methyl-D-tryptophan structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$302.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Boc-5-methyl-D-tryptophan
IUPAC Name(R)-2-((tert-butoxycarbonyl)amino)-3-(5-methyl-1H-indol-3-yl)propanoic acid
MDL No.MFCD10565745
Molecular FormulaC17H22N2O4
Molecular Weight318.37
SMILESCC1=CC2=C(NC=C2C[C@@H](NC(=O)OC(C)(C)C)C(O)=O)C=C1
InChI KeyLXTPSKBAIKOFNX-CQSZACIVSA-N
SynonymN-BOC-5-METHYL-D-TRYPTOPHAN;D-Tryptophan, N-[(1,1-dimethylethoxy)carbonyl]-5-methyl-;Boc-D-5-MethylTryptophan;(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(5-methyl-1H-indol-3-yl)propanoic acid;(2R)-3-(5-methyl-1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;(R)-2-((tert-butoxycarbonyl)amino)-3-(5-methyl-1H-indol-3-yl)propanoic acid
CAS No.114873-18-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBHGN835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKZMJ381 route compound structure diagram
    ACKZMJ38199295-79-1 In Stock
  4. Then
  5. ACBHGN835 route product structure diagram
    ACBHGN835114873-18-6
Inquiry

2. ACBHGN835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBHGN835 route product structure diagram
    ACBHGN835114873-18-6
Inquiry

Comments (0)